Form 4 for PEPG PepGen Inc.
Accepted 2024-07-26 00:00:00 ET · period of report 2024-07-24 · accession 0001127602-24-021044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-26 | 2024-07-24+ | PEPG | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +7,772 | 201 | New | +$79.4K |
| DM | 2024-07-26 | 2024-07-24+ | PEPG | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.06 | -7,772 | 0 | -100% | -$140.4K |
| DM | 2024-07-26 | 2024-07-24+ | PEPG | Mellion Michelle L | Chief Medical Off | M - OptEx | $0.00 | -7,772 | 57.6K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-25 | M | A | 7,571 | $10.21 | 7,571 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-24 | M | A | 201 | $10.21 | 201 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-24 | S | D | 201 | $18.01 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-07-25 | S | D | 7,571 | $18.06 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-07-25 | M | D | 7,571 | $0.00 | 50,000 | D | $10.21 · — to 2032-06-30 | 7,571 Common Stock | (F4) This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-07-24 | M | D | 201 | $0.00 | 57,571 | D | $10.21 · — to 2032-06-30 | 201 Common Stock | (F4) This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. |